114 related articles for article (PubMed ID: 2826518)
1. Intratypic differentiation of poliovirus strains by enzyme-linked immunosorbent assay (ELISA): poliovirus type 2 and poliovirus type 3.
Glikmann G; Pedersen M; Petersen I
J Virol Methods; 1987 Oct; 18(1):25-36. PubMed ID: 2826518
[TBL] [Abstract][Full Text] [Related]
2. Intratypic differentiation of poliovirus strains by enzyme-linked immunosorbent assay (ELISA): poliovirus type 1.
Glikmann G; Moynihan M; Petersen I; Vestergaard BF
Dev Biol Stand; 1983; 55():199-208. PubMed ID: 6203794
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of molecular and antigenic characterization for intratypic differentiation (ITD) of poliovirus strains.
Adedeji AO; Okonko IO; Adu FD
J Med Virol; 2012 Dec; 84(12):1975-9. PubMed ID: 23080505
[TBL] [Abstract][Full Text] [Related]
4. Improvement of methods for intratypic differentiation of polioviruses. II. Use of strain-specific antisera cross-adsorbed with antigens of heterologous strains in agar gel diffusion precipitation test for differentiation between wild and vaccine strains of poliovirus typess 1,2 and 3.
Rubin SG; Chumakov MP; Savinskaya SS; Pervikov YV; Gracheva LA; Voroshilova MK
Arch Gesamte Virusforsch; 1974; 46(1-2):66-70. PubMed ID: 4374168
[No Abstract] [Full Text] [Related]
5. Poliovirus-binding inhibition ELISA for evaluation of immune response to oral poliovirus vaccine: a possible alternative to the neutralization test.
Ivanov AP; Dragunsky EM; Ivanova OE; Rezapkin GV; Potapova SG; Chumakov KM
Hum Vaccin; 2005; 1(3):102-5. PubMed ID: 17012865
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of poliovirus type I isolates in the 1982 epidemic from Sabin-I strain by antigenic and temperature markers.
Lee CN; Kao CL; Lee CY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):80-8. PubMed ID: 3036431
[TBL] [Abstract][Full Text] [Related]
7. Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method.
Rezapkin G; Martin J; Chumakov K
Biologicals; 2005 Mar; 33(1):29-39. PubMed ID: 15713554
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
Sawyer LA; McInnis J; Albrecht P
Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
[TBL] [Abstract][Full Text] [Related]
9. Intratypic characterization of poliovirus type 1 isolates.
Deshpande JM; Dave KH
Indian J Med Res; 1991 Jul; 93():202-7. PubMed ID: 1660032
[TBL] [Abstract][Full Text] [Related]
10. Antigenic and biochemical characterization of poliovirus type 1 isolates.
Hara M; Arita M; Yamazaki Z; Hagiwara A; Saito Y
Microbiol Immunol; 1987; 31(4):327-36. PubMed ID: 3039316
[TBL] [Abstract][Full Text] [Related]
11. Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains.
Kersten G; Hazendonk T; Beuvery C
Vaccine; 1999 Apr; 17(15-16):2059-66. PubMed ID: 10217607
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of an ELISA kit made in our laboratory for intratypic discrimination of poliovirus type 1 strains isolated from acute flask paralysis].
Ozkaya E; Arita M
Mikrobiyol Bul; 2002 Jan; 36(1):71-7. PubMed ID: 12476769
[TBL] [Abstract][Full Text] [Related]
13. Universal ELISA for quantification of D-antigen in inactivated poliovirus vaccines.
Kouiavskaia D; Puligedda RD; Dessain SK; Chumakov K
J Virol Methods; 2020 Feb; 276():113785. PubMed ID: 31765719
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the immune response of the rabbit to virulent and attenuated strains of type 1 poliovirus.
Gaudin OG; Viac J; Thouvenot D; Sohier R
Bull World Health Organ; 1974; 50(6):479-5. PubMed ID: 4376464
[TBL] [Abstract][Full Text] [Related]
15. Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV).
Rezapkin G; Dragunsky E; Chumakov K
Biologicals; 2005 Mar; 33(1):17-27. PubMed ID: 15713553
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies to polioviruses. Comparison of intratypic strain differentiation of poliovirus type 1 using monoclonal antibodies versus cross-absorbed antisera.
Osterhaus AD; van Wezel AL; Hazendonk TG; UytdeHaag FG; van Asten JA; van Steenis B
Intervirology; 1983; 20(2-3):129-36. PubMed ID: 6313544
[TBL] [Abstract][Full Text] [Related]
17. Strain differentiation of polioviruses with monoclonal antibodies.
Osterhaus AD; van Wezel AL; Stegmann AJ; van Asten JA; Hazendonk AG
Dev Biol Stand; 1984; 57():135-9. PubMed ID: 6098494
[TBL] [Abstract][Full Text] [Related]
18. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains.
Osterhaus AD; van Wezel AL; van Steenis B; Drost GA; Hazendonk TG
Intervirology; 1981; 16(4):218-24. PubMed ID: 6177658
[TBL] [Abstract][Full Text] [Related]
20. Induction of neutralizing antibodies by poliovirus capsid polypeptides VP1, VP2 and VP3.
van der Marel P; Hazendonk TG; Henneke MA; van Wezel AL
Vaccine; 1983 Dec; 1(1):17-22. PubMed ID: 6099638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
